Arena Pharmaceuticals DSO Ratio 2011-2026 | ARNA

Annual DSO Ratio Arena Pharmaceuticals

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	946	1.53	75.6	193	59.4	47	36.6	47.5	73.5	17.4

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
946	1.53	150

Quarterly DSO Ratio Arena Pharmaceuticals

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	-	-	-	335	50.9	119	219	0.47	53.7	130	116	194	14	89.1	113	80.5	13.7	95.6	193	116	58.1	49.3	49	32.2	36.9	41.5	26.5	95.8	148	270	14	311	262	341	23.1	128	26.7	16	17	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
341	0.47	108

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 215.54	-1.16 %	$ 5 B	Danmark
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aquestive Therapeutics AQST	103	$ 3.88	-1.27 %	$ 415 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amphastar Pharmaceuticals AMPH	70.9	$ 19.23	-	$ 899 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.18	-2.97 %	$ 109 M	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
bluebird bio BLUE	2.47	-	-	$ 546 M	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
CollPlant Biotechnologies Ltd. CLGN	9.68	$ 0.71	17.15 %	$ 8.13 M	Israel
CytomX Therapeutics CTMX	12.3	$ 4.24	-4.83 %	$ 585 M	USA
Cyclacel Pharmaceuticals CYCC	81.5 K	-	-5.98 %	$ 34.1 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Genmab A/S GMAB	97.9	$ 25.81	0.51 %	$ 16.6 B	Danmark
Aytu BioScience AYTU	150	$ 2.65	0.76 %	$ 16.6 M	USA
Dynavax Technologies Corporation DVAX	56.5	-	-	$ 2.02 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Eton Pharmaceuticals ETON	39.1	$ 22.97	-3.53 %	$ 618 M	USA
Exelixis EXEL	43.4	$ 41.57	0.39 %	$ 11.3 B	USA
Fortress Biotech FBIO	80.5	$ 2.92	-2.01 %	$ 60.7 M	USA
Arbutus Biopharma Corporation ABUS	50	$ 4.31	-2.49 %	$ 826 M	Canada